ROYAL BANK OF CANADA - CTI BIOPHARMA CORP ownership

Back to all holdings Add to watchlist

CTI BIOPHARMA CORP's ticker is CTICXXXX and the CUSIP is 12648L106. A total of 90 filers reported holding CTI BIOPHARMA CORP in Q4 2014. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q2 2016$0–566
+249.4%
0.00%–
Q4 2015$0
-100.0%
162
-97.8%
0.00%–
Q3 2015$11,000
-38.9%
7,438
-19.0%
0.00%–
Q2 2015$18,000–9,184
+13815.2%
0.00%–
Q1 2015$0–660.0%0.00%–
Q4 2014$0–66
-50.4%
0.00%–
Q3 2014$0–133–0.00%–
 Download
Other shareholders

There were no reported owners of CTI BIOPHARMA CORP in Q4 2014.

NameSharesValueWeighting ↓
View complete list of CTI BIOPHARMA CORP shareholders